Similarly, in epithelial ovarian cancer tissues, IL-36α was downregulated compared to controls and reduction in IL-36α expression was associated with tumor progression and poor overall prognosis (Chang et al., 2017). This evidence concerns the gene IL36A and ovarian carcinoma.